Install
Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com
- 189articles · 30d
- 8+ hour agolatest article
- Aug 14, 2026earliest in window
- 89%with images
- 245avg words
- Medical 139
- Health & Wellness 102
- Economy, Business & Finance 81
- Health 75
- Business & Industrial 65
- Finance & Business 33
- Science & Technology 21
- News 15
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Novo Nordisk trial finds semaglutide cuts obesity in children aged 6–11
3+ day, 23+ hour ago (63+ words) The findings are particularly significant because the trial population had a high burden of severe obesity Novo Nordisk trial finds semaglutide cuts obesity in children aged 6–11 MED-EL launches SONNET 3 cochlear implant audio processor in India Apollo Hospitals Navi Mumbai launches…...
SMT enters Canadian market with Health Canada licence for Supraflex Cruz coronary stent
3+ day, 16+ hour ago (430+ words) Sahajanand Medical Technologies Limited (SMT) has received a Class IV medical device licence from Health Canada’s Medical Devices Directorate for its Supraflex Cruz sirolimus-eluting coronary stent system, marking the company’s entry into the Canadian market. The family licence covers the…...
Novartis’ pelacarsen trial fails to cut cardiovascular risk
4+ day, 22+ hour ago (54+ words) The pivotal cardiovascular outcomes trial did not meet its primary endpoint FDA moves to boost estradiol patch supply as demand surges Superluminal Medicines raises $60 million to push obesity drug into clinic Novartis’ pelacarsen trial fails to cut cardiovascular risk Indian…...
Superluminal Medicines raises $60 million to push obesity drug into clinic
5+ day, 3+ hour ago (62+ words) Indian Pharma Post Superluminal Medicines raises $60 million to push obesity drug into clinic Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The complexity of compliance The…...
Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial
6+ day, 22+ hour ago (68+ words) Indian Pharma Post Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The…...
Gan & Lee signs up to €726 million Menarini deal for obesity drug in Europe
1+ week, 4+ hour ago (61+ words) The deal gives Gan & Lee a major European partner as the Chinese pharmaceutical company seeks to turn bofanglutide into a global metabolic-health product Priyanka Tewari appointed Head of Marketing at Glenmark Pharma Sonika Natalkar joins Lupin as Deputy General Manager…...
Lilly’s Taltz-Zepbound combination delivers stronger one-year results in psoriatic disease & obesity trials
1+ week, 5+ day ago (85+ words) indianpharmapost.com Lilly’s Taltz-Zepbound combination delivers stronger one-year results in psoriatic disease & obesity trials The results build on statistically superior outcomes reported at Week 36, when the combination outperformed Taltz alone on key disease and metabolic measures Chasing Consistency: Centralizing operations…...
Lilly to acquire Merida Biosciences for $2.875 billion in autoimmune disease push
1+ week, 5+ day ago (65+ words) Merida's lead drug candidate, MER511, is already being tested in a Phase 1 trial for Graves' disease and thyroid eye disease Lilly to acquire Merida Biosciences for $2.875 billion in autoimmune disease push Sun Pharma joins White House push on US drug pricing…...
Aurobindo Pharma subsidiary launches generic Advair Diskus in US
1+ week, 6+ day ago (207+ words) Lannett company commercialises first product from its inhalation pipeline in two strengths Aurobindo Pharma USA’s wholly owned subsidiary Lannett Company LLC has launched the generic equivalent of Advair Diskus® (fluticasone propionate and salmeterol inhalation powder) in the US market. The…...
Zydus’ Saroglitazar Mg clears key hurdle in global MASH trial
1+ week, 6+ day ago (73+ words) EVIDENCES-X trial met its primary endpoint, with a 26.5% treatment difference in MASH resolution without worsening of fibrosis Dr. Rajesh Nair appointed CEO of Park Group of Hospitals India cuts malaria cases and deaths by nearly 80% over a decade IPC launches…...